Reaction
Aortic Valve Sclerosis reporting signals
As of the last recalculation, Aortic Valve Sclerosis appears in 725 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is DIGOXIN (PRR 32.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Digoxin | 74 | 32.9 | 32.9 |
| Cimetidine | 10 | 30.2 | 30.2 |
| Zidovudine | 11 | 24.0 | 24.0 |
| Eplerenone | 10 | 22.7 | 22.7 |
| Exemestane | 16 | 21.9 | 21.9 |
| Raltegravir | 12 | 21.2 | 21.2 |
| Darunavir | 11 | 21.2 | 21.2 |
| Gemfibrozil | 11 | 21.1 | 21.1 |
| Paricalcitol | 9 | 18.5 | 18.5 |
| Quinapril Hydrochloride | 5 | 18.3 | 18.3 |
| Amiodarone Hydrochloride | 7 | 18.1 | 18.1 |
| Ritonavir 100 Mg | 8 | 15.5 | 15.5 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 8.6 | 8.6 |
| Tafamidis | 3 | 7.3 | 7.3 |
| Cortisone Acetate | 3 | 7.0 | 7.0 |
| Hydrocodone Bitartrate | 9 | 6.0 | 6.0 |